Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS)

[Edit]

AAA; AAASb; ADRACALA; Aladin; Adracalin; Allgrove,Triple-A; Alacrima-Achalasia-Adrenal Insufficiency Neurologic Disorder

Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS)
AAAS is a member of the WD-repeat family of regulatory proteins and may be involved in normal development of the peripheral and central nervous system. The encoded protein is part of the nuclear pore complex and is anchored there by NDC1. Defects in this gene are a cause of achalasia-addisonianism-alacrima syndrome (AAAS).Two transcript variants encoding different isoforms have been found for this gene. AAAS, encoding a 547-amino acid protein, called aladin, that was mutant in affected individuals. Aladin (for ) belongs to the WD-repeat family of regulatory proteins, indicating a new disease mechanism involved in the triple-A syndrome. The expression of the gene in both neuroendocrine and cerebral structures pointed to a role in the normal development of the peripheral and central nervous systems.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) CLIA Kit Customized Service Offer
n/a ELISA Kit for Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) CLIA Kit Customized Service Offer
n/a ELISA Kit for Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) CLIA Kit Customized Service Offer
n/a ELISA Kit for Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) ELISA Kit Customized Service Offer
  1. "Mutant WD-repeat protein in triple-A syndrome."Nat. Genet. 26:332-335(2000) [PubMed] [Europe PMC] [Abstract]
  2. "Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene."Hum. Mol. Genet. 10:283-290(2001) [PubMed] [Europe PMC] [Abstract]
  3. "Molecular cloning and characterization of AAAS-V2, a novel splice variant of human AAAS."Mol. Biol. Rep. 32:127-131(2005) [PubMed] [Europe PMC] [Abstract]
  4. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  5. "The finished DNA sequence of human chromosome 12." Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract]
  6. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  7. "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
  8. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  9. "The nuclear pore complex protein ALADIN is anchored via NDC1 but not via POM121 and GP210 in the nuclear envelope."Biochem. Biophys. Res. Commun. 390:205-210(2009) [PubMed] [Europe PMC] [Abstract]
  10. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  11. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  12. "Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features."Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012) [PubMed] [Europe PMC] [Abstract]
  13. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
  14. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]